NCT06910852已完成不适用
Hepatic and Portal Vein Transection by Vascular Stapler in Open Living Donor Hepatectomy
Abdalla Bashir, MD1 个研究点 分布在 1 个国家目标入组 17 人开始时间: 2021年6月18日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 17
- 试验地点
- 1
- 主要终点
- Post-operative complications (Clavien-Dindo classification)
研究概览
简要总结
To enhance donor safety in living donor liver transplantation (LDLT), the use of vascular staplers for the division of the right portal and hepatic veins in patients undergoing right lobe liver donation has been introduced. This study examines the application of vascular staplers in LDLT and assesses the subsequent feasibility and safety outcomes for donors.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Retrospective
入排标准
- 年龄范围
- 18 Years 至 80 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients undergoing open living donor hepatectomy
- •Age ≥ 18 years, ≤ 80 years
- •Written informed consent
排除标准
- 未提供
结局指标
主要结局
Post-operative complications (Clavien-Dindo classification)
时间窗: From enrollment to the end of treatment at 6 weeks
次要结局
未报告次要终点
研究者
Abdalla Bashir, MD
MD
Jordan Hospital
研究点 (1)
Loading locations...
相似试验
Unknown
不适用
The Use of Technical Vessel Sealing Devices for Recipient Hepatectomy in Liver TransplantationHepatectomyNCT03323242University Hospital Heidelberg69
Unknown
不适用
Impact of Splenic Artery Ligation in LDLT for Patients With Portal HypertensionLiving Donor Liver TransplantationNCT04988100Assiut University30
已完成
不适用
Hepatic and Portal Vein Transection by Vascular Stapler in Living Donor Liver Transplantatioiver transplantB18.19B18.2K74.5E83.0I82.0C22.0Chronic viral hepatitis CBiliary cirrhosis, unspecifiedDisorders of copper metabolismLiver cell carcinomaBudd-Chiari syndromeDRKS00028573Jordan Hospital Amman17
已完成
不适用
Risk Factors and a nOmogram of Venous thromboEmbolism in Patients After liveR Transplantation(ROVER Study)Liver TransplantationVenous ThromboembolismNCT05209048Beijing Tsinghua Chang Gung Hospital356
已完成
不适用
Expanding Donor Pool for Live Donor Liver Transplantation: Utilization of Donors With NASH After OptimizationNon Alcoholic SteatohepatitisNCT04571957Institute of Liver and Biliary Sciences, India410